208 related articles for article (PubMed ID: 22167476)
1. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
Poultsides GA; Huang LC; Cameron JL; Tuli R; Lan L; Hruban RH; Pawlik TM; Herman JM; Edil BH; Ahuja N; Choti MA; Wolfgang CL; Schulick RD
Ann Surg Oncol; 2012 Jun; 19(6):1928-35. PubMed ID: 22167476
[TBL] [Abstract][Full Text] [Related]
2. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
4. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
[TBL] [Abstract][Full Text] [Related]
7. What prognostic factors are important in duodenal adenocarcinoma?
Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
10. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
Rose DM; Hochwald SN; Klimstra DS; Brennan MF
J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
[TBL] [Abstract][Full Text] [Related]
11. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
Augustin T; Moslim MA; Cengiz TB; El-Hayek K; Simon R; Bhatt A; Tang A; Burke CA; Matthew Walsh R
J Surg Oncol; 2020 Nov; 122(6):1132-1144. PubMed ID: 33124067
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of radical resection for locally advanced duodenal adenocarcinoma.
Bucher P; Gervaz P; Morel P
Hepatogastroenterology; 2005; 52(66):1727-9. PubMed ID: 16334766
[TBL] [Abstract][Full Text] [Related]
15. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
16. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
[TBL] [Abstract][Full Text] [Related]
18. Does lymph node ratio impact survival in resected periampullary malignancies?
Hurtuk MG; Hughes C; Shoup M; Aranha GV
Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
[TBL] [Abstract][Full Text] [Related]
19. The histopathologic type of the periampullary tumors. Is it important for survival?
Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.
Sarela AI; Brennan MF; Karpeh MS; Klimstra D; Conlon KC
Ann Surg Oncol; 2004 Apr; 11(4):380-6. PubMed ID: 15070597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]